Suppr超能文献

草药疗法在软骨组织工程中的潜力:新治疗方法和策略的概述。

Herbal Remedies as Potential in Cartilage Tissue Engineering: An Overview of New Therapeutic Approaches and Strategies.

机构信息

Musculoskeletal Research Group and Tumour Biology, Chair of Vegetative Anatomy, Institute of Anatomy, Faculty of Medicine, Ludwig-Maximilian-University Munich, Pettenkoferstrasse 11, D-80336 Munich, Germany.

Department of Anatomical Sciences, School of Medicine, Isfahan University of Medical Sciences, Isfahan 73461-81746, Iran.

出版信息

Molecules. 2020 Jul 6;25(13):3075. doi: 10.3390/molecules25133075.

Abstract

It is estimated that by 2023, approximately 20% of the population of Western Europe and North America will suffer from a degenerative joint disease commonly known as osteoarthritis (OA). During the development of OA, pro-inflammatory cytokines are one of the major causes that drive the production of inflammatory mediators and thus of matrix-degrading enzymes. OA is a challenging disease for doctors due to the limitation of the joint cartilage's capacity to repair itself. Though new treatment approaches, in particular with mesenchymal stem cells (MSCs) that integrate the tissue engineering (TE) of cartilage tissue, are promising, they are not only expensive but more often do not lead to the regeneration of joint cartilage. Therefore, there is an increasing need for novel, safe, and more effective alternatives to promote cartilage joint regeneration and TE. Indeed, naturally occurring phytochemical compounds (herbal remedies) have a great anti-inflammatory, anti-oxidant, and anabolic potential, and they have received much attention for the development of new therapeutic strategies for the treatment of inflammatory diseases, including the prevention of age-related OA and cartilage TE. This paper summarizes recent research on herbal remedies and their chondroinductive and chondroprotective effects on cartilage and progenitor cells, and it also emphasizes the possibilities that exist in this research area, especially with regard to the nutritional support of cartilage regeneration and TE, which may not benefit from non-steroidal anti-inflammatory drugs (NSAIDs).

摘要

据估计,到 2023 年,西欧和北美的大约 20%的人口将患有退行性关节疾病,通常称为骨关节炎(OA)。在 OA 的发展过程中,促炎细胞因子是驱动炎症介质产生的主要原因之一,进而导致基质降解酶的产生。OA 是一种令医生感到棘手的疾病,因为关节软骨自我修复的能力有限。尽管新的治疗方法,特别是使用整合软骨组织工程(TE)的间充质干细胞(MSCs),具有广阔的前景,但这些方法不仅昂贵,而且往往不能导致关节软骨的再生。因此,需要寻找新型、安全且更有效的替代方法来促进软骨关节再生和 TE。事实上,天然存在的植物化学化合物(草药)具有很强的抗炎、抗氧化和合成代谢潜力,它们已成为治疗炎症性疾病(包括预防与年龄相关的 OA 和软骨 TE)的新治疗策略的热点,包括预防与年龄相关的 OA 和软骨 TE。本文总结了最近关于草药的研究,以及它们对软骨和祖细胞的软骨诱导和软骨保护作用,还强调了该研究领域存在的可能性,特别是在软骨再生和 TE 的营养支持方面,这可能无法受益于非甾体抗炎药(NSAIDs)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6afd/7411884/3d81cb05e677/molecules-25-03075-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验